Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Airborne Movement of Antibiotic Resistance Genes Between Livestock Stables and Farmers' Homes.
Journal: Microorganisms
Published: February 17, 2026
Three decades of anaplastic lymphoma kinase: from physiological roles to cancer and immune evasion.
Journal: Cancer metastasis reviews
Published: November 30, 2025
Effect of periodontal therapy on the oral microbiome and lung function: an intervention study.
Journal: Frontiers in cellular and infection microbiology
Published: October 28, 2025
Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: September 06, 2025
Longitudinal impact of oral bacteria and endotoxin on lung function.
Journal: European clinical respiratory journal
Published: August 18, 2025
Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma.
Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: August 15, 2025
Airborne Microbial Signatures of Sleep Apnea Risk: Enrichment of Human-Associated and Loss of Environmental Taxa.
Journal: Journal of sleep research
Published: July 23, 2025
Growth Hormone Pathway as a Prognostic and Therapeutic Biomarker in Patients With Unresectable Hepatocellular Carcinoma Treated With Radiation Therapy.
Journal: Advances in radiation oncology
Published: July 10, 2025
Indoor airborne bacterial communities and adult lung health: A cross-sectional study.
Journal: International journal of hygiene and environmental health
Published: June 19, 2025
Climate change and indoor biological exposures: a hidden risk to immune health.
Journal: Frontiers in public health
Published: March 21, 2025
Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab.
Journal: Cancer biomarkers : section A of Disease markers
Published: September 13, 2024
Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.
Journal: Oncology
Published: June 26, 2024
Last Updated: 09/26/2026